-
Signature
-
/s/ Melodie T. Morin, Attorney-in-Fact for Stephen Williamson
-
Stock symbol
-
TMO
-
Transactions as of
-
Feb 3, 2025
-
Transactions value $
-
-$6,590,021
-
Form type
-
4
-
Date filed
-
2/5/2025, 04:46 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TMO |
Common Stock |
Options Exercise |
$2.5M |
+9.83K |
+35.99% |
$253.99 |
37.1K |
Feb 3, 2025 |
Direct |
F1 |
| transaction |
TMO |
Common Stock |
Sale |
-$5.83M |
-9.83K |
-26.47% |
$593.13 |
27.3K |
Feb 3, 2025 |
Direct |
F2 |
| transaction |
TMO |
Common Stock |
Options Exercise |
$2.5M |
+9.83K |
+35.99% |
$253.99 |
37.1K |
Feb 4, 2025 |
Direct |
|
| transaction |
TMO |
Common Stock |
Sale |
-$5.75M |
-9.83K |
-26.47% |
$585.59 |
27.3K |
Feb 4, 2025 |
Direct |
F2 |
| holding |
TMO |
Common Stock |
|
|
|
|
|
12.7K |
Feb 3, 2025 |
By SLAT |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
TMO |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-9.83K |
-50% |
$0.00 |
9.83K |
Feb 3, 2025 |
Common Stock |
9.83K |
$253.99 |
Direct |
F4 |
| transaction |
TMO |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-9.83K |
-100% |
$0.00 |
0 |
Feb 4, 2025 |
Common Stock |
9.83K |
$253.99 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: